Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
Ziruoyu Wang, Yanan Li, Wensi Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 2
Multi Omics Applications in Biological Systems
Cristian D. Gutierrez Reyes, Gerardo Alejo‐Jacuinde, Benjamin Perez Sanchez, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5777-5793
Open Access | Times Cited: 13
Emerging trends and hot topics in the application of multi-omics in drug discovery: A bibliometric and visualized study
Ziheng Wang, Yang Zhao, Long Zhang
Current Pharmaceutical Analysis (2024) Vol. 21, Iss. 1, pp. 20-32
Open Access | Times Cited: 5
Self‐Powered Electrically Controlled Drug Release Systems Based on Nanogenerator
Weikang Luo, Ruizeng Luo, Jingjing Liu, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 10
Closed Access | Times Cited: 12
Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell anti-tumor immunity
Qian Yu, Dong Yu, Xiaobo Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 4
Integrating multiomics analysis and machine learning to refine the molecular subtyping and prognostic analysis of stomach adenocarcinoma
Miaodong Wang, Qin He, Zeshan Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
N-terminal histone acetyltransferase NAA40 modulates osteosarcoma progression by controlling AGR2 expression
Hanhua Wu, Xu Hua, Yu-Nan Man, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 754, pp. 151491-151491
Closed Access
Human cytomegalovirus UL82 promotes cell cycle progression of colorectal cancer by upregulating AGR2
Haitao Ren, Bing Wang, Lanni Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells
Stephen Hsien-Chi Yuan, Chih‐Ching Wu, Yu‐Chih Wang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Molecular Biology: Challenges and Opportunities
Madhav Bhatia
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 109-109
Open Access
A Multi-Omics-Empowered Framework for Precision Diagnosis and Treatment of Lysosomal Diseases
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyen Quang Thu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101274-101274
Open Access
Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications
Fatima M. Al-Daffaie, Sara F. Al-Mudhafar, Aya Alhomsi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5071-5071
Open Access | Times Cited: 3
AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment
Shen Qu, Weili Jia, Ye Nie, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 743-743
Open Access | Times Cited: 2
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification
Sana Hachem, Amani Yehya, Jad El Masri, et al.
Biology (2024) Vol. 13, Iss. 10, pp. 762-762
Open Access | Times Cited: 1
Proteomics Identifies LUC7L3 as a Prognostic Biomarker for Hepatocellular Carcinoma
Yushan Hou, Siqi Wang, Yiming Zhang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4004-4020
Open Access | Times Cited: 1
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
Najeha Anwardeen, Khaled Naja, Mohamed A. Elrayess
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Multiomics approaches in cancer
Huma Hameed, Saleha Faheem, Muhammad Zaman, et al.
Elsevier eBooks (2024), pp. 53-72
Closed Access
Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research
Abdalla Elbialy, Deepthi Kappala, Dhruv Desai, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1005-1005
Open Access
Elucidating Cancer Subtypes by Using Epigenome and Genome Cross-Talk
Muneeba Jilani, Nurit Haspel
Lecture notes in computer science (2024), pp. 3-16
Closed Access
Emerging Combination Strategy: FANCI Inhibition Induces PARP1 Redistribution to Enhance Efficacy of PARP Inhibitors in Breast Cancer
Yuzhou Huang, Ming‐Yi Sang, Pei-Wen Xi, et al.
Research Square (Research Square) (2023)
Open Access
Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis
Laura Menotti, Andrea Vannini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17378-17378
Open Access
Identifying drug sensitivity of multifocal primary prostate cancer
Juening Kang, Panagiotis Chouvardas, Katja Ovchinnikova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top